aluates Reports

$ 0.0

Automative

Global Retroviral Vectors Market Research Report 2024

Published Date: January 2025

Report Code: QYRE-Auto-15F18914

BUY CHAPTERS

Global Retroviral Vectors Market Research Report 2024

Code: QYRE-Auto-15F18914

Report

January 2025

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Merck KGaA

Biovian

Esco Lifesciences Group

ABL, Inc.

Genezen

AGC Inc. Group (AGC Biologics)

Thermo Fisher Scientific Inc

Creative Biogene

CD Bioparticles

Charles River Laboratories

Avid Bioservices Inc.

Retroviral Vectors Market Size

The global market for Retroviral Vectors was valued at US$ 412 million in the year 2023 and is projected to reach a revised size of US$ 797 million by 2030, growing at a CAGR of 8.7% during the forecast period.

Retroviral Vectors Market

Retroviral vectors transduce a wide range of hard-to-infect dividing cells and integrate into the host genome, which makes them ideal for long-term, stable expression of your transgene.As the number and variety of planned CAR-T and gene therapy trials increases with each year, the need for commercial-grade retrovirus also continues to grow.

North American market for Retroviral Vectors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Retroviral Vectors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Retroviral Vectors in Gene Therapy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Retroviral Vectors include Merck KGaA, Biovian, Esco Lifesciences Group, ABL, Inc., Genezen, AGC Inc. Group (AGC Biologics), Thermo Fisher Scientific Inc., Creative Biogene, CD Bioparticles, Charles River Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Retroviral Vectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Retroviral Vectors.

The Retroviral Vectors market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Retroviral Vectors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Retroviral Vectors companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Retroviral Vectors Market Report

Report Metric	Details
Report Name	Retroviral Vectors Market
Accounted market size in year	US$ 412 million
Forecasted market size in 2030	US$ 797 million
CAGR	8.7%
Base Year	year
Forecasted years	2025 - 2030
Segment by Type	Research / Preclinical Grade Clinical Grade Commercial Grade
Segment by Application	Gene Therapy Vaccine Development Cell Therapy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck KGaA, Biovian, Esco Lifesciences Group, ABL, Inc., Genezen, AGC Inc. Group (AGC Biologics), Thermo Fisher Scientific Inc., Creative Biogene, CD Bioparticles, Charles River Laboratories, Avid Bioservices, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Retroviral Vectors company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Retroviral Vectors Market growing?

Ans: The Retroviral Vectors Market witnessing a CAGR of 8.7% during the forecast period 2025-2030.

What is the Retroviral Vectors Market size in 2030?

Ans: The Retroviral Vectors Market size in 2030 will be US$ 797 million.

Who are the main players in the Retroviral Vectors Market report?

Ans: The main players in the Retroviral Vectors Market are Merck KGaA, Biovian, Esco Lifesciences Group, ABL, Inc., Genezen, AGC Inc. Group (AGC Biologics), Thermo Fisher Scientific Inc., Creative Biogene, CD Bioparticles, Charles River Laboratories, Avid Bioservices, Inc.

What are the Application segmentation covered in the Retroviral Vectors Market report?

Ans: The Applications covered in the Retroviral Vectors Market report are Gene Therapy, Vaccine Development, Cell Therapy

What are the Type segmentation covered in the Retroviral Vectors Market report?

Ans: The Types covered in the Retroviral Vectors Market report are Research / Preclinical Grade, Clinical Grade, Commercial Grade

Recommended Reports

Gene Therapy Markets

Viral & Vector Markets

Cell & Immuno Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Retroviral Vectors Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Research / Preclinical Grade

1.2.3 Clinical Grade

1.2.4 Commercial Grade

1.3 Market by Application

1.3.1 Global Retroviral Vectors Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Gene Therapy

1.3.3 Vaccine Development

1.3.4 Cell Therapy

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Retroviral Vectors Market Perspective (2019-2030)

2.2 Global Retroviral Vectors Growth Trends by Region

2.2.1 Global Retroviral Vectors Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Retroviral Vectors Historic Market Size by Region (2019-2024)

2.2.3 Retroviral Vectors Forecasted Market Size by Region (2025-2030)

2.3 Retroviral Vectors Market Dynamics

2.3.1 Retroviral Vectors Industry Trends

2.3.2 Retroviral Vectors Market Drivers

2.3.3 Retroviral Vectors Market Challenges

2.3.4 Retroviral Vectors Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Retroviral Vectors Players by Revenue

3.1.1 Global Top Retroviral Vectors Players by Revenue (2019-2024)

3.1.2 Global Retroviral Vectors Revenue Market Share by Players (2019-2024)

3.2 Global Retroviral Vectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Retroviral Vectors Revenue

3.4 Global Retroviral Vectors Market Concentration Ratio

3.4.1 Global Retroviral Vectors Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Retroviral Vectors Revenue in 2023

3.5 Global Key Players of Retroviral Vectors Head office and Area Served

3.6 Global Key Players of Retroviral Vectors, Product and Application

3.7 Global Key Players of Retroviral Vectors, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Retroviral Vectors Breakdown Data by Type

4.1 Global Retroviral Vectors Historic Market Size by Type (2019-2024)

4.2 Global Retroviral Vectors Forecasted Market Size by Type (2025-2030)

5 Retroviral Vectors Breakdown Data by Application

5.1 Global Retroviral Vectors Historic Market Size by Application (2019-2024)

5.2 Global Retroviral Vectors Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Retroviral Vectors Market Size (2019-2030)

6.2 North America Retroviral Vectors Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Retroviral Vectors Market Size by Country (2019-2024)

6.4 North America Retroviral Vectors Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Retroviral Vectors Market Size (2019-2030)

7.2 Europe Retroviral Vectors Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Retroviral Vectors Market Size by Country (2019-2024)

7.4 Europe Retroviral Vectors Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Retroviral Vectors Market Size (2019-2030)

8.2 Asia-Pacific Retroviral Vectors Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Retroviral Vectors Market Size by Region (2019-2024)

8.4 Asia-Pacific Retroviral Vectors Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Retroviral Vectors Market Size (2019-2030)

9.2 Latin America Retroviral Vectors Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Retroviral Vectors Market Size by Country (2019-2024)

9.4 Latin America Retroviral Vectors Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Retroviral Vectors Market Size (2019-2030)

10.2 Middle East & Africa Retroviral Vectors Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Retroviral Vectors Market Size by Country (2019-2024)

10.4 Middle East & Africa Retroviral Vectors Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Merck KGaA

11.1.1 Merck KGaA Company Details

11.1.2 Merck KGaA Business Overview

11.1.3 Merck KGaA Retroviral Vectors Introduction

11.1.4 Merck KGaA Revenue in Retroviral Vectors Business (2019-2024)

11.1.5 Merck KGaA Recent Development

11.2 Biovian

11.2.1 Biovian Company Details

11.2.2 Biovian Business Overview

11.2.3 Biovian Retroviral Vectors Introduction

11.2.4 Biovian Revenue in Retroviral Vectors Business (2019-2024)

11.2.5 Biovian Recent Development

11.3 Esco Lifesciences Group

11.3.1 Esco Lifesciences Group Company Details

11.3.2 Esco Lifesciences Group Business Overview

11.3.3 Esco Lifesciences Group Retroviral Vectors Introduction

11.3.4 Esco Lifesciences Group Revenue in Retroviral Vectors Business (2019-2024)

11.3.5 Esco Lifesciences Group Recent Development

11.4 ABL, Inc.

11.4.1 ABL, Inc. Company Details

11.4.2 ABL, Inc. Business Overview

11.4.3 ABL, Inc. Retroviral Vectors Introduction

11.4.4 ABL, Inc. Revenue in Retroviral Vectors Business (2019-2024)

11.4.5 ABL, Inc. Recent Development

11.5 Genezen

11.5.1 Genezen Company Details

11.5.2 Genezen Business Overview

11.5.3 Genezen Retroviral Vectors Introduction

11.5.4 Genezen Revenue in Retroviral Vectors Business (2019-2024)

11.5.5 Genezen Recent Development

11.6 AGC Inc. Group (AGC Biologics)

11.6.1 AGC Inc. Group (AGC Biologics) Company Details

11.6.2 AGC Inc. Group (AGC Biologics) Business Overview

11.6.3 AGC Inc. Group (AGC Biologics) Retroviral Vectors Introduction

11.6.4 AGC Inc. Group (AGC Biologics) Revenue in Retroviral Vectors Business (2019-2024)

11.6.5 AGC Inc. Group (AGC Biologics) Recent Development

11.7 Thermo Fisher Scientific Inc.

11.7.1 Thermo Fisher Scientific Inc. Company Details

11.7.2 Thermo Fisher Scientific Inc. Business Overview

11.7.3 Thermo Fisher Scientific Inc. Retroviral Vectors Introduction

11.7.4 Thermo Fisher Scientific Inc. Revenue in Retroviral Vectors Business (2019-2024)

11.7.5 Thermo Fisher Scientific Inc. Recent Development

11.8 Creative Biogene

11.8.1 Creative Biogene Company Details

11.8.2 Creative Biogene Business Overview

11.8.3 Creative Biogene Retroviral Vectors Introduction

11.8.4 Creative Biogene Revenue in Retroviral Vectors Business (2019-2024)

11.8.5 Creative Biogene Recent Development

11.9 CD Bioparticles

11.9.1 CD Bioparticles Company Details

11.9.2 CD Bioparticles Business Overview

11.9.3 CD Bioparticles Retroviral Vectors Introduction

11.9.4 CD Bioparticles Revenue in Retroviral Vectors Business (2019-2024)

11.9.5 CD Bioparticles Recent Development

11.10 Charles River Laboratories

11.10.1 Charles River Laboratories Company Details

11.10.2 Charles River Laboratories Business Overview

11.10.3 Charles River Laboratories Retroviral Vectors Introduction

11.10.4 Charles River Laboratories Revenue in Retroviral Vectors Business (2019-2024)

11.10.5 Charles River Laboratories Recent Development

11.11 Avid Bioservices, Inc.

11.11.1 Avid Bioservices, Inc. Company Details

11.11.2 Avid Bioservices, Inc. Business Overview

11.11.3 Avid Bioservices, Inc. Retroviral Vectors Introduction

11.11.4 Avid Bioservices, Inc. Revenue in Retroviral Vectors Business (2019-2024)

11.11.5 Avid Bioservices, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Merck KGaA

Biovian

Esco Lifesciences Group

ABL, Inc.

Genezen

AGC Inc. Group (AGC Biologics)

Thermo Fisher Scientific Inc

Creative Biogene

CD Bioparticles

Charles River Laboratories

Avid Bioservices Inc.

List of Tables

Table 1. Global Retroviral Vectors Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Research / Preclinical Grade

Table 3. Key Players of Clinical Grade

Table 4. Key Players of Commercial Grade

Table 5. Global Retroviral Vectors Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Retroviral Vectors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Retroviral Vectors Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Retroviral Vectors Market Share by Region (2019-2024)

Table 9. Global Retroviral Vectors Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Retroviral Vectors Market Share by Region (2025-2030)

Table 11. Retroviral Vectors Market Trends

Table 12. Retroviral Vectors Market Drivers

Table 13. Retroviral Vectors Market Challenges

Table 14. Retroviral Vectors Market Restraints

Table 15. Global Retroviral Vectors Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Retroviral Vectors Market Share by Players (2019-2024)

Table 17. Global Top Retroviral Vectors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retroviral Vectors as of 2023)

Table 18. Ranking of Global Top Retroviral Vectors Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Retroviral Vectors Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Retroviral Vectors, Headquarters and Area Served

Table 21. Global Key Players of Retroviral Vectors, Product and Application

Table 22. Global Key Players of Retroviral Vectors, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Retroviral Vectors Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Retroviral Vectors Revenue Market Share by Type (2019-2024)

Table 26. Global Retroviral Vectors Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Retroviral Vectors Revenue Market Share by Type (2025-2030)

Table 28. Global Retroviral Vectors Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Retroviral Vectors Revenue Market Share by Application (2019-2024)

Table 30. Global Retroviral Vectors Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Retroviral Vectors Revenue Market Share by Application (2025-2030)

Table 32. North America Retroviral Vectors Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Retroviral Vectors Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Retroviral Vectors Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Retroviral Vectors Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Retroviral Vectors Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Retroviral Vectors Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Retroviral Vectors Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Retroviral Vectors Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Retroviral Vectors Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Retroviral Vectors Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Retroviral Vectors Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Retroviral Vectors Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Retroviral Vectors Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Retroviral Vectors Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Retroviral Vectors Market Size by Country (2025-2030) & (US$ Million)

Table 47. Merck KGaA Company Details

Table 48. Merck KGaA Business Overview

Table 49. Merck KGaA Retroviral Vectors Product

Table 50. Merck KGaA Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)

Table 51. Merck KGaA Recent Development

Table 52. Biovian Company Details

Table 53. Biovian Business Overview

Table 54. Biovian Retroviral Vectors Product

Table 55. Biovian Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)

Table 56. Biovian Recent Development

Table 57. Esco Lifesciences Group Company Details

Table 58. Esco Lifesciences Group Business Overview

Table 59. Esco Lifesciences Group Retroviral Vectors Product

Table 60. Esco Lifesciences Group Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)

Table 61. Esco Lifesciences Group Recent Development

Table 62. ABL, Inc. Company Details

Table 63. ABL, Inc. Business Overview

Table 64. ABL, Inc. Retroviral Vectors Product

Table 65. ABL, Inc. Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)

Table 66. ABL, Inc. Recent Development

Table 67. Genezen Company Details

Table 68. Genezen Business Overview

Table 69. Genezen Retroviral Vectors Product

Table 70. Genezen Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)

Table 71. Genezen Recent Development

Table 72. AGC Inc. Group (AGC Biologics) Company Details

Table 73. AGC Inc. Group (AGC Biologics) Business Overview

Table 74. AGC Inc. Group (AGC Biologics) Retroviral Vectors Product

Table 75. AGC Inc. Group (AGC Biologics) Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)

Table 76. AGC Inc. Group (AGC Biologics) Recent Development

Table 77. Thermo Fisher Scientific Inc. Company Details

Table 78. Thermo Fisher Scientific Inc. Business Overview

Table 79. Thermo Fisher Scientific Inc. Retroviral Vectors Product

Table 80. Thermo Fisher Scientific Inc. Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)

Table 81. Thermo Fisher Scientific Inc. Recent Development

Table 82. Creative Biogene Company Details

Table 83. Creative Biogene Business Overview

Table 84. Creative Biogene Retroviral Vectors Product

Table 85. Creative Biogene Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)

Table 86. Creative Biogene Recent Development

Table 87. CD Bioparticles Company Details

Table 88. CD Bioparticles Business Overview

Table 89. CD Bioparticles Retroviral Vectors Product

Table 90. CD Bioparticles Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)

Table 91. CD Bioparticles Recent Development

Table 92. Charles River Laboratories Company Details

Table 93. Charles River Laboratories Business Overview

Table 94. Charles River Laboratories Retroviral Vectors Product

Table 95. Charles River Laboratories Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)

Table 96. Charles River Laboratories Recent Development

Table 97. Avid Bioservices, Inc. Company Details

Table 98. Avid Bioservices, Inc. Business Overview

Table 99. Avid Bioservices, Inc. Retroviral Vectors Product

Table 100. Avid Bioservices, Inc. Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)

Table 101. Avid Bioservices, Inc. Recent Development

Table 102. Research Programs/Design for This Report

Table 103. Key Data Information from Secondary Sources

Table 104. Key Data Information from Primary Sources

Table 105. Authors List of This Report

List of Figures

Figure 1. Retroviral Vectors Picture

Figure 2. Global Retroviral Vectors Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Retroviral Vectors Market Share by Type: 2023 VS 2030

Figure 4. Research / Preclinical Grade Features

Figure 5. Clinical Grade Features

Figure 6. Commercial Grade Features

Figure 7. Global Retroviral Vectors Market Size by Application (2024-2030) & (US$ Million)

Figure 8. Global Retroviral Vectors Market Share by Application: 2023 VS 2030

Figure 9. Gene Therapy Case Studies

Figure 10. Vaccine Development Case Studies

Figure 11. Cell Therapy Case Studies

Figure 12. Retroviral Vectors Report Years Considered

Figure 13. Global Retroviral Vectors Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Retroviral Vectors Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Retroviral Vectors Market Share by Region: 2023 VS 2030

Figure 16. Global Retroviral Vectors Market Share by Players in 2023

Figure 17. Global Top Retroviral Vectors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retroviral Vectors as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Retroviral Vectors Revenue in 2023

Figure 19. North America Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Retroviral Vectors Market Share by Country (2019-2030)

Figure 21. United States Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Retroviral Vectors Market Share by Country (2019-2030)

Figure 25. Germany Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Retroviral Vectors Market Share by Region (2019-2030)

Figure 33. China Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Retroviral Vectors Market Share by Country (2019-2030)

Figure 41. Mexico Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Retroviral Vectors Market Share by Country (2019-2030)

Figure 45. Turkey Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. UAE Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Merck KGaA Revenue Growth Rate in Retroviral Vectors Business (2019-2024)

Figure 49. Biovian Revenue Growth Rate in Retroviral Vectors Business (2019-2024)

Figure 50. Esco Lifesciences Group Revenue Growth Rate in Retroviral Vectors Business (2019-2024)

Figure 51. ABL, Inc. Revenue Growth Rate in Retroviral Vectors Business (2019-2024)

Figure 52. Genezen Revenue Growth Rate in Retroviral Vectors Business (2019-2024)

Figure 53. AGC Inc. Group (AGC Biologics) Revenue Growth Rate in Retroviral Vectors Business (2019-2024)

Figure 54. Thermo Fisher Scientific Inc. Revenue Growth Rate in Retroviral Vectors Business (2019-2024)

Figure 55. Creative Biogene Revenue Growth Rate in Retroviral Vectors Business (2019-2024)

Figure 56. CD Bioparticles Revenue Growth Rate in Retroviral Vectors Business (2019-2024)

Figure 57. Charles River Laboratories Revenue Growth Rate in Retroviral Vectors Business (2019-2024)

Figure 58. Avid Bioservices, Inc. Revenue Growth Rate in Retroviral Vectors Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Viral Vector Manufacturing Market Research Report 2024

Global Lentiviral Vectors Market Research Report 2024

Viral Vector Production Research use Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Viral Vectors Market Research Report 2024

Global Viral Vector Based Gene Therapy Market Research Report 2025

Global Viral Vector Manufacturing for Gene Therapy Market Research Report 2024

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2025

Global Viral Vectors Non Viral Vectors and Gene Therapy Manufacturing Market Research Report 2024

Viral Vector and Plasmid DNA Testing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Viral Vector Based Gene Therapy Drugs Market Research Report 2024

Global Gene Therapy Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Viral and Non viral Vector Market Research Report 2024

Global Viral Vector Development and Manufacturing Services Market Research Report 2025

Global Gene Therapy For Cancer Market Research Report 2024

Global Retrovirus Based Gene Therapy Drugs Market Research Report 2024

Global Cell Transfection Technology Market Research Report 2024

Global Vector Based RNAi Market Research Report 2024

Global Research Grade Viral Vector Packaging Service Market Research Report 2025

Adeno Associated Virus AAV Vector Based Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

120 Pages

Type: Report

Code: QYRE-Auto-21N6899

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13M6952

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29X7355

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28B293

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Retroviral Vectors Market Research Report 2024

Published Date: January 2025

Report Code: QYRE-Auto-15F18914

Global Retroviral Vectors Market Research Report 2024

FEATURED COMPANIES

Retroviral Vectors Market Size

Retroviral Vectors Market

Scope of Retroviral Vectors Market Report

Chapter Outline

FAQ for this report

How fast is Retroviral Vectors Market growing?

What is the Retroviral Vectors Market size in 2030?

Who are the main players in the Retroviral Vectors Market report?

What are the Application segmentation covered in the Retroviral Vectors Market report?

What are the Type segmentation covered in the Retroviral Vectors Market report?

Recommended Reports

Gene Therapy Markets

Viral & Vector Markets

Cell & Immuno Therapy

FEATURED COMPANIES

RELATED REPORTS